
152.79 Delayed Data As of Mar 24 | ![]() Today’s Change | 95.02 Today|||52-Week Range 153.64 | +12.89% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $237.9B |
Novo Nordisk A/S Novo Allé 1 Bagsværd Capital Region 2880 |
Lars Fruergaard Jørgensen | President & Chief Executive Officer |
Maziar Mike Doustdar | Executive Vice President-International Operations |
Karsten Munk Knudsen | Chief Financial Officer & Executive Vice President |
Henrik Ehlers Wulff | Executive VP & Head-Information Technology |
Stephen Gough | Global Chief Medical Officer |